Bromodomain Inhibitors Modulate FcγR-Mediated Mononuclear Phagocyte Activation and Chemotaxis

Bromodomain Inhibitors Modulate FcγR-Mediated Mononuclear Phagocyte Activation and Chemotaxis

IgG antibodies form immune complexes (IC) that propagate inflammation and tissue damage in autoimmune diseases such as systemic lupus erythematosus. IgG IC engage Fcγ receptors (FcγR) on mononuclear phagocytes (MNP), leading to widespread changes in gene expression that mediate antibody effector fun...

Full description

Bibliographic Details
Main Authors:	Gemma D. Banham, Colin Y. C. Lee, John R. Ferdinand, Rebeccah J. Matthews, Chenzhi Jing, Nicholas Smithers, Rab K. Prinjha, Menna R. Clatworthy
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Immunology
Subjects:	BET inhibitors systemic lupus erythematosus (SLE) Fcγ-receptor dendritic cell chemotaxis antibody-mediated inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.885101/full

Similar Items

IgG and Fcγ Receptors in Intestinal Immunity and Inflammation
by: Tomas Castro-Dopico, et al.
Published: (2019-04-01)

Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel
by: Haizhang Chen, et al.
Published: (2022-01-01)

CHEMOTAXIS OF PHAGOCYTES IS SIGNIFICANT IN ESTIMATION OF INDIVIDUAL DOSAGE OF DRUGS FOR CORRECTION OF LOCOMOTIVE PHAGOCYTE DISFUNCTIONS IN CHILDREN WITH TRAUMA
by: O. N. Zlakomanova, et al.
Published: (2014-07-01)

Chemotaxis /
by: 348966 Eisenbach, Michael, et al.
Published: (2004)

Mucosal IgG in inflammatory bowel disease – a question of (sub)class?
by: Tomas Castro-Dopico, et al.
Published: (2020-11-01)

Inhibition of BET Proteins Regulates Fcγ Receptor Function and Reduces Inflammation in Rheumatoid Arthritis
by: Divya Shankar, et al.
Published: (2023-04-01)

Impacts of FcγRIIB and FcγRIIIA gene polymorphisms on systemic lupus erythematous disease activity index
by: Mansoor Karimifar, et al.
Published: (2021-12-01)

The Role of Bromodomain and Extraterminal (BET) Proteins in Controlling the Phagocytic Activity of Microglia In Vitro: Relevance to Alzheimer’s Disease
by: Marta Matuszewska, et al.
Published: (2022-12-01)

BET bromodomain inhibition promotes neurogenesis while inhibiting gliogenesis in neural progenitor cells
by: Jingjun Li, et al.
Published: (2016-09-01)

Roles of Bromodomain Extra Terminal Proteins in Metabolic Signaling and Diseases
by: Dayu Wu, et al.
Published: (2022-08-01)

Bromodomain Protein Inhibitors Reorganize the Chromatin of Synovial Fibroblasts
by: Monika Krošel, et al.
Published: (2023-04-01)

Autoantibodies in SLE: Specificities, Isotypes and Receptors
by: Barbara Dema, et al.
Published: (2016-01-01)

Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivo
by: Asif J Iqbal, et al.
Published: (2016-08-01)

Homeostatic role of B-1 cells in tissue immunity
by: Ondrej Suchanek, et al.
Published: (2023-09-01)

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy
by: Khiyam Hussain, et al.
Published: (2022-04-01)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
by: Takuo Suzuki, et al.
Published: (2021-01-01)

How Phagocytes Acquired the Capability of Hunting and Removing Pathogens From a Human Body: Lessons Learned From Chemotaxis and Phagocytosis of Dictyostelium discoideum (Review)
by: Xuehua Xu, et al.
Published: (2021-08-01)

Multiplexed microfluidic screening of bacterial chemotaxis
by: Michael R Stehnach, et al.
Published: (2023-07-01)

Spotlight on Plant Bromodomain Proteins
by: Eirini Bardani, et al.
Published: (2023-08-01)

Role of Glutathione in Neutrophil Chemotaxis in Periodontitis
by: Nurul Iman Binti Badlishah Sham, et al.
Published: (2023-11-01)

The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies
by: Céline Monnet, et al.
Published: (2021-08-01)

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods
by: Christophe Dumet, et al.
Published: (2023-03-01)

A Review of the Advantages, Disadvantages and Limitations of Chemotaxis Assays for <i>Campylobacter</i> spp.
by: Bassam A. Elgamoudi, et al.
Published: (2022-01-01)

In Silico Reconstruction of Sperm Chemotaxis
by: Masahiro Naruse, et al.
Published: (2021-08-01)

The Novel Protein Cj0371 Inhibits Chemotaxis of Campylobacter jejuni
by: Xueqing Du, et al.
Published: (2018-08-01)

Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation
by: Christopher Beneduce, et al.
Published: (2023-08-01)

BACTERIAL CHEMOTAXIS AND FLAVONOIDS: PROSPECTS FOR THE USE OF PROBIOTICS
by: Monica Marcela Galicia Jimenez, et al.
Published: (2011-08-01)

IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target
by: Yasmine Lamri, et al.
Published: (2020-12-01)

Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro
by: Omar S. Qureshi, et al.
Published: (2024-12-01)

Sperm chemotaxis in marine invertebrates and mammals
by: Hang Kang, et al.
Published: (2017-01-01)

Recent advances in neutrophil chemotaxis abnormalities during sepsis
by: Yu-Ying Zhou, et al.
Published: (2022-11-01)

Sperm chemotaxis is driven by the slope of the chemoattractant concentration field
by: Héctor Vicente Ramírez-Gómez, et al.
Published: (2020-03-01)

Logistic Regression of Ligands of Chemotaxis Receptors Offers Clues about Their Recognition by Bacteria
by: Takashi Sagawa, et al.
Published: (2018-01-01)

Biocompatible High-Resolution 3D-Printed Microfluidic Devices: Integrated Cell Chemotaxis Demonstration
by: Mawla Boaks, et al.
Published: (2023-08-01)

Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
by: Wendy Mao, et al.
Published: (2019-10-01)

BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma
by: Elisa Funck-Brentano, et al.
Published: (2021-01-01)

Cytoskeletal Protein 4.1R Is a Positive Regulator of the FcεRI Signaling and Chemotaxis in Mast Cells
by: Lubica Draberova, et al.
Published: (2020-01-01)

On blow-up criteria for a coupled chemotaxis fluid model
by: Hongyan Xie, et al.
Published: (2017-01-01)

Asymptotic behavior for small mass in an attraction-repulsion chemotaxis system
by: Yuhuan Li, et al.
Published: (2015-06-01)

Adaptability of non-genetic diversity in bacterial chemotaxis
by: Nicholas W Frankel, et al.
Published: (2014-10-01)